CRON
Cronos Group Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$3.26
+0.00%Margins
Gross margin
33.5%
EBITDA margin
10.0%
EBIT margin
5.1%
Net margin
28.7%
FCF margin
18.3%
6.5%
Return on equity
5.9%
Return on assets
1.2%
Return on invested capital
0.21x
Asset turnover
$54.9M
Cash from operations
$2.16
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026